Verified stock metrics
Prelude Therapeutics Incorporated - Common Stock Key Stock Metrics
Prelude Therapeutics Incorporated - Common Stock (PRLD) market cap, valuation,…
Direct answer
Prelude Therapeutics Incorporated - Common Stock has 7 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked August 8, 2026.
Verified data
- Market capitalization
- $390.26M
- Price-to-book ratio
- 6.72x
- Dividend yield
- 0%
- 52-week price range
- $0.75 to $5.69
- Return on equity
- -95.25%
- Profit margin
- 0%
- Debt-to-equity ratio
- 29.45%
Explore related company data
View Prelude Therapeutics Incorporated - Common Stock's market capitalizationView Prelude Therapeutics Incorporated - Common Stock's price-to-book ratioView Prelude Therapeutics Incorporated - Common Stock's dividend yieldView Prelude Therapeutics Incorporated - Common Stock's 52-week price rangeView Prelude Therapeutics Incorporated - Common Stock's return on equityView Prelude Therapeutics Incorporated - Common Stock's profit marginView Prelude Therapeutics Incorporated - Common Stock's debt-to-equity ratioReturn to Prelude Therapeutics Incorporated - Common Stock profile